Agranulocytosis including fatal cases has also been reported. Nicolson, SE; Nemeroff, CB December 2007. Nemeroff CB, Lieberman JA, Weiden PJ, et al. November 2005. Using the two medicines together may cause an irregular heartbeat, which may be life-threatening. Weight gain has been observed with atypical antipsychotic use. Monitoring of weight is recommended. ases.info casodex
This medication may increase a certain natural substance prolactin made by your body. Take Ziprasidone hydrochloride capsules only as directed by your doctor. If you have schizophrenia, you are more likely to develop diabetes than people who do not have schizophrenia, and taking ziprasidone or similar medications may increase this risk. Tell your doctor immediately if you have any of the following symptoms while you are taking ziprasidone: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar that is not treated can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.
Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate. Ziprasidone hydrochloride monohydrate is a white to slightly pink powder. Newman-Tancredi A, Gavaudan S, Conte C, et al. August 1998. RxList is part of the WebMD Health Network. The opinions expressed in the WebMD User Reviews are solely those of the User, who may or may not have medical or scientific training, and do not represent the opinions of WebMD. These member reviews have not been reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other purpose except for compliance with our Terms and Conditions.
Ziprasidone hydrochloride and have their WBC followed until recovery. This medication can decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Ziprasidone is not approved for use in psychotic conditions related to dementia. Ziprasidone may increase the risk of death in older adults with dementia-related conditions. Ziprasidone hydrochloride capsules should be administered at an initial daily dose of 20 mg twice daily with food. In some patients, daily dosage may subsequently be adjusted on the basis of individual clinical status up to 80 mg twice daily. Dosage adjustments, if indicated, should generally occur at intervals of not less than 2 days, as steady-state is achieved within 1 to 3 days. In order to ensure use of the lowest effective dose, patients should ordinarily be observed for improvement for several weeks before upward dosage adjustment.
Call your doctor immediately if you take more than the amount of Ziprasidone hydrochloride capsules prescribed by your doctor. Geodon ziprasidone hydrochloride US prescribing information. Pfizer Inc. CYP3A4 have been shown to decrease and increase, respectively, blood levels of ziprasidone. This drug may rarely make your blood sugar level rise, which can cause or worsen diabetes. Tell your doctor right away if you develop symptoms of high blood sugar, such as increased thirst and urination. If you already have diabetes, be sure to check your blood sugars regularly. Your doctor may need to adjust your diabetes medication, exercise program, or diet. Its biological half-life time is 10 hours at doses of 80-120 milligrams. Keating AM, Aoun SL, Dean CE 2005. Use this on the only. However, not use it on the face or underarms unless directed to do so by your doctor. Some products are meant to be used on the scalp for various conditions. To correctly use these products, follow the directions on the product package. Ask your pharmacist for a list of the ingredients. Take this medication by mouth with food as directed by your doctor, usually twice daily. Swallow the capsules whole. British Journal of Clinical Pharmacology. About FAERS: The FDA Adverse Event Reporting System FAERS is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. This medication may rarely cause a very serious condition called neuroleptic syndrome NMS. Is ziprasidone available as a generic drug?
Requip; ketoconazole Nizoral; medications for high blood pressure, mental illness, seizures, or anxiety; and sedatives, sleeping pills, or tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. This drug may also rarely cause significant weight gain and a rise in your blood cholesterol or triglyceride levels. These effects, along with diabetes, may increase your risk for developing heart disease. Discuss the risks and benefits of treatment with your doctor. Ziprasidone's for most of the and and the are high and its affinity for the is moderate. Do not share this medication with others. NMS can occur with all antipsychotic medications including Ziprasidone hydrochloride. Signs of NMS include very high fever, rigid muscles, shaking, confusion, sweating, or increased heart rate and blood pressure. NMS is a rare but serious side effect that could be fatal. Therefore, tell your doctor if you experience any of these signs. If any of these effects persist or worsen, tell your doctor or promptly. Ziprasidone hydrochloride is a type of prescription medicine called a psychotropic, also known as an atypical antipsychotic. Ziprasidone hydrochloride can be used to treat symptoms of schizophrenia. Because of its potential for inducing hypotension, Ziprasidone may enhance the effects of certain antihypertensive agents. Because of this, Ziprasidone hydrochloride should be used only after your doctor has considered this risk for Ziprasidone hydrochloride against the risks and benefits of other medications available for treating schizophrenia. Dosage adjustments are generally not required on the basis of age, gender, race, or renal or hepatic impairment. Ziprasidone hydrochloride is not approved for use in children or adolescents. Keep all drug products away from children and pets. Keep all regular medical and laboratory appointments. There was no evidence to suggest that these developmental effects were secondary to maternal toxicity. This summary contains important information about Ziprasidone hydrochloride capsules. It is not meant to take the place of your doctor's instructions. Read this information carefully before you take Ziprasidone hydrochloride capsules. Ask your doctor or pharmacist if you do not understand any of this information or if you want to know more about Ziprasidone hydrochloride capsules. Although the prevalence of the syndrome appears to be highest among the elderly, especially elderly women, it is impossible to rely upon prevalence estimates to predict, at the inception of antipsychotic treatment, which patients are likely to develop the syndrome. Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown. Given these considerations, Ziprasidone should be prescribed in a manner that is most likely to minimize the occurrence of tardive dyskinesia. Chronic antipsychotic treatment should generally be reserved for patients who suffer from a chronic illness that 1 is known to respond to antipsychotic drugs, and 2 for whom alternative, equally effective, but potentially less harmful treatments are not available or appropriate. In patients who do require chronic treatment, the smallest dose and the shortest duration of treatment producing a satisfactory clinical response should be sought. The need for continued treatment should be reassessed periodically. claritin
Ziprasidone's efficacy in treating the positive symptoms of schizophrenia is believed to be mediated primarily via antagonism of the dopamine receptors, specifically D 2. Blockade of the 5-HT 2A receptor may also play a role in its effectiveness against positive symptoms, though the significance of this property in antipsychotic drugs is still debated among researchers. Blockade of 5-HT 2A and 5-HT 2C and activation of 5-HT 1A as well as inhibition of the reuptake of serotonin and norepinephrine may all contribute to its ability to alleviate negative symptoms. Adverse reactions during exposure were obtained by collecting voluntarily reported adverse experiences, as well as results of physical examinations, vital signs, weights, laboratory analyses, ECGs, and results of ophthalmologic examinations. Ziprasidone was documented in 10 patients. All of these patients survived without sequelae. Recently, the FDA required the manufacturers of some atypical antipsychotics to include a warning about the risk of and with atypical antipsychotics. What is ziprasidone, and how does it work mechanism of action? Australia Therapeutic Goods Administration. February 24, 2016. Heinz Lüllmann; Klaus Mohr 2006. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristics of the patients is not clear. The American Journal of Psychiatry. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first. People in your neighborhood are plotting to harass you.
Cardiovascular monitoring should commence immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias. If antiarrhythmic therapy is administered, disopyramide, procainamide, and quinidine carry a theoretical hazard of additive QT-prolonging effects that might be additive to those of Ziprasidone. The effect of Ziprasidone on labor and delivery in humans is unknown. Tell your doctor if you plan to do vigorous exercise or be exposed to extreme heat. Neuroleptic Malignant Syndrome NMS has been reported in association with administration of antipsychotic drugs. Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status, and evidence of autonomic instability irregular pulse or blood pressure, tachycardia, diaphoresis, and cardiac dysrhythmia. Additional signs may include elevated creatinine phosphokinase, myoglobinuria rhabdomyolysis and acute renal failure. Davis R, Risch SC April 2002. Before taking Ziprasidone hydrochloride capsules, tell your doctor if you are pregnant or plan on becoming pregnant. It is advised that you don't breast feed an infant if you are taking Ziprasidone hydrochloride capsules. While there is no body of evidence available to answer the question of how long a patient treated with Ziprasidone should remain on it, a maintenance study in patients who had been symptomatically stable and then randomized to continue Ziprasidone or switch to placebo demonstrated a delay in time to relapse for patients receiving Ziprasidone hydrochloride. Many people using this medication not have serious side effects. Class Ia and III anti-arrhythmics, mesoridazine, thioridazine, chlorpromazine, droperidol, pimozide, sparfloxacin, gatifloxacin, moxifloxacin, halofantrine, mefloquine, pentamidine, arsenic trioxide, levomethadyl acetate, dolasetron mesylate, probucol or tacrolimus. network atrovent
The risk of developing tardive dyskinesia and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic drugs administered to the patient increase. However, the syndrome can develop, although much less commonly, after relatively brief treatment periods at low doses. Tschoner A, Engl J, Rettenbacher M, et al. January 2009. As with other antipsychotic drugs and placebo, sudden unexplained deaths have been reported in patients taking Ziprasidone at recommended doses. The premarketing experience for Ziprasidone did not reveal an excess risk of mortality for Ziprasidone compared to other antipsychotic drugs or placebo, but the extent of exposure was limited, especially for the drugs used as active controls and placebo. Nevertheless, Ziprasidone's larger prolongation of QTc length compared to several other antipsychotic drugs raises the possibility that the risk of sudden death may be greater for Ziprasidone than for other available drugs for treating schizophrenia. Ziprasidone hydrochloride capsules contain a monohydrochloride, monohydrate salt of Ziprasidone. Tell your doctor if your condition persists or worsens. Citrome, L; Yang, R; Glue, P; Karayal, ON June 2009. "Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials. For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products. Ziprasidone. There were confounding factors that may have contributed to the occurrence of seizures in many of these cases. Your doctor may want you to get additional laboratory tests to see if Ziprasidone hydrochloride capsule is an appropriate treatment for you.
Ziprasidone patients compared to no median weight change in placebo patients. Patients with neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur. Ziprasidone hydrochloride capsules have not been shown to be safe or effective in the treatment of children and teenagers under the age of 18 years old. It is recommended that patients being considered for Ziprasidone treatment who are at risk for significant electrolyte disturbances, hypokalemia in particular, have baseline serum potassium and magnesium measurements. Undesirable alterations in lipids have been observed in patients treated with atypical antipsychotics. Pooled data from short-term, placebo-controlled studies in schizophrenia are presented in Tables 3-4. Ziprasidone frequently causes 1 in 7 patients. Therefore, care should be exercised in any activity requiring mental alertness, such as operating a motor vehicle including automobiles or operating hazardous machinery. Less common side effects include 1 in 250 patients. It is also important to remember that Ziprasidone hydrochloride capsules should be taken with food. Retrieved June 19, 2015. Extrapyramidal Symptoms EPS The incidence of reported EPS which included the adverse reaction terms extrapyramidal syndrome, hypertonia, dystonia, dyskinesia, hypokinesia, tremor, paralysis and twitching for Ziprasidone-treated patients in the short-term, placebo-controlled schizophrenia trials was 14% vs. 8% for placebo. Objectively collected data from those trials on the Simpson-Angus Rating Scale for EPS and the Barnes Akathisia Scale for akathisia did not generally show a difference between Ziprasidone and placebo. PANSS on two consecutive days. Ziprasidone was significantly superior to placebo in time to relapse, with no significant difference between the different dose groups. There were insufficient data to examine population subsets based on age and race. Examination of population subsets based on gender did not reveal any differential responsiveness. Ziprasidone is known to cause activation into mania in some bipolar patients. Do I need a prescription for ziprasidone? Any patient treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. Patients who develop symptoms of hyperglycemia during treatment with atypical antipsychotics should undergo fasting blood glucose testing. In some cases, hyperglycemia has resolved when the atypical antipsychotic was discontinued; however, some patients required continuation of antidiabetic treatment despite discontinuation of the suspect drug. Ziprasidone hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. where to buy real coversyl
The diagnostic evaluation of patients with this syndrome is complicated. While these symptoms can occur at low doses, they occur more frequently and with greater severity with high potency and at higher doses of first generation antipsychotic drugs. An elevated risk of acute dystonia is observed in males and younger age groups. Patients should be instructed to take Ziprasidone hydrochloride capsules with food for optimal absorption. In vivo studies have revealed no effect of Ziprasidone on the pharmacokinetics of estrogen or progesterone components. Food and Drug Administration. WebMD does not endorse any specific product, service or treatment. Because Ziprasidone is highly metabolized, with less than 1% of the drug excreted unchanged, renal impairment alone is unlikely to have a major impact on the pharmacokinetics of Ziprasidone. Population pharmacokinetic analysis of schizophrenic patients enrolled in controlled clinical trials has not revealed evidence of any clinically significant pharmacokinetic interactions with benztropine, propranolol, or lorazepam. Ziprasidone hydrochloride capsules, 20 mg are size '4' capsules with dark blue opaque cap and white opaque body, imprinted axially with "LU" on cap and "V51" on body in black ink, containing off-white to pinkish granular powder. Discuss the risks and benefits with your doctor. This medication is a mild corticosteroid. FDA, which approved the drug on February 5, 2001.
Take Ziprasidone hydrochloride capsules with food. Ziprasidone hydrochloride capsules contain Ziprasidone hydrochloride monohydrate, lactose monohydrate, pregelatinized maize starch, and magnesium stearate. Tell your doctor promptly if redness, swelling, or irritation does not improve. After a single dose intramuscular administration, the peak serum concentration typically occurs at about 60 minutes after the dose is administered, or earlier. Steady state plasma concentrations are achieved within one to three days. Exposure increases in a dose-related manner and following three days of intramuscular dosing, little accumulation is observed. Any patient developing symptoms that suggest diabetes during treatment should be tested for diabetes. Patients should be instructed to report the onset of any conditions that put them at risk for significant electrolyte disturbances, hypokalemia in particular, including but not limited to the initiation of diuretic therapy or prolonged diarrhea. If a patient requires antipsychotic drug treatment after recovery from NMS, the potential reintroduction of drug therapy should be carefully considered. The patient should be carefully monitored, since recurrences of NMS have been reported. Swallow the capsules whole. Wash and dry your hands before using. Clean and dry the affected area. If you are using the lotion or foam, shake it well just before using. If you are using the spray, check the product package to see if it needs to be shaken before each use. Apply a small amount of medication to the affected area and gently rub in, usually up to 4 times a day or as directed by your doctor or the product package. Dosage and length of treatment depends on the type of condition being treated. Do not bandage, cover, or wrap the area unless directed to do so by your doctor. Dizziness caused by a drop in your blood pressure may occur with Ziprasidone hydrochloride, especially when you first start taking this medication or when the dose is increased. If this happens, be careful not to stand up too quickly, and talk to your doctor about the problem. glucophage
Only your doctor can decide if Ziprasidone hydrochloride capsules are right for you. The government is spying on you. Antagonism at receptors other than dopamine and 5HT 2 with similar receptor affinities may explain some of the other therapeutic and side effects of Ziprasidone. Ziprasidone's antagonism of histamine H 1 receptors may explain the somnolence observed with this drug. Ziprasidone's antagonism of α 1-adrenergic receptors may explain the orthostatic hypotension observed with this drug. Ziprasidone is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. Ziprasidone is a selective monoaminergic antagonist with high affinity for the serotonin Type 2 5HT2 dopamine Type 2 D2 1 and 2 adrenergic, and H1 histaminergic receptors. Ziprasidone acts as an antagonist at other receptors, but with lower potency. Antagonism at receptors other than dopamine and 5HT2 with similar receptor affinities may explain some of the other therapeutic and side effects of Ziprasidone. Ziprasidone's antagonism of muscarinic M1-5 receptors may explain its anticholinergic effects. Ziprasidone's antagonism of histamine H1 receptors may explain the somnolence observed with this drug. Ziprasidone's antagonism of adrenergic a1 receptors may explain the orthostatic hypotension observed with this drug. Other severe cutaneous adverse reactions, such as Stevens-Johnson syndrome, have been reported with Ziprasidone exposure. Severe cutaneous adverse reactions are sometimes fatal. Discontinue Ziprasidone if severe cutaneous adverse reactions are suspected. Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company CHLIC. In Arizona, individual HMO plans are insured by Cigna HealthCare of Arizona, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company CGLIC or their affiliates see a that insure or administer group HMO, dental HMO, and other products or services in your state. Group Universal Life GUL insurance plans are insured by CGLIC. Life other than GUL accident, critical illness, and disability plans are insured or administered by Life Insurance Company of North America, except in NY, where insured plans are offered by Cigna Life Insurance Company of New York. All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico. Ziprasidone is contraindicated in individuals with a known hypersensitivity to the product. Ziprasidone, and all patients experiencing these reactions were reported to recover completely. Upon appearance of rash for which an alternative etiology cannot be identified, Ziprasidone should be discontinued. There are some medications that may be unsafe to use when taking Ziprasidone hydrochloride, and there are some medicines that can affect how well Ziprasidone hydrochloride works. When ziprasidone is taken with moxifloxacin or sparfloxacin, the effects on your heart may be increased. Ziprasidone 20 and 60 mg twice daily with placebo, only the 60 mg dose was superior to placebo on the BPRS total score and the CGI severity score. This higher dose group was not superior to placebo on the BPRS psychosis cluster or on the SANS. It is best to take Ziprasidone hydrochloride capsules at the same time each day. You are currently taking medications that should not be taken in combination with Ziprasidone, for example, dofetilide, sotalol, quinidine, other Class Ia and III anti-arrhythmics, mesoridazine, thioridazine, chlorpromazine, droperidol, pimozide, sparfloxacin, gatifloxacin, moxifloxacin, halofantrine, mefloquine, pentamidine, arsenic trioxide, levomethadyl acetate, dolasetron mesylate, probucol or tacrolimus. Ziprasidone with valproate is unlikely due to the lack of common metabolic pathways for the two drugs.
Based on in vitro studies utilizing human liver enzymes, Ziprasidone is not a substrate for CYP1A2; smoking should therefore not have an effect on the pharmacokinetics of Ziprasidone. Consistent with these in vitro results, population pharmacokinetic evaluation has not revealed any significant pharmacokinetic differences between smokers and nonsmokers. Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition. Retrieved December 12, 2014. Stinging, burning, irritation, dryness, or redness at the application site may occur. Ziprasidone was tested in the Ames bacterial mutation assay, the in vitro mammalian cell gene mutation mouse lymphoma assay, the in vitro chromosomal aberration assay in human lymphocytes, and the in vivo chromosomal aberration assay in mouse bone marrow. There was a reproducible mutagenic response in the Ames assay in one strain of S. typhimurium in the absence of metabolic activation. Positive results were obtained in both the in vitro mammalian cell gene mutation assay and the in vitro chromosomal aberration assay in human lymphocytes. Your spouse or partner is cheating on you. Miceli JJ, Glue P, Alderman J, Wilner K 2007. "The effect of food on the absorption of oral ziprasidone". Psychopharmacology Bulletin. In the second phase of the study, the effect of Ziprasidone on QTc length was not augmented by the presence of a metabolic inhibitor ketoconazole 200 mg twice daily. Gilman's The Pharmacological Basis of Therapeutics 12th Edition. China: McGraw-Hill. Roland Seifert; Thomas Wieland; Raimund Mannhold; Hugo Kubinyi; Gerd Folkers July 17, 2006. Many drugs besides ziprasidone may affect the heart rhythm QT prolongation including amiodarone, dofetilide, moxifloxacin, pimozide, procainamide, quinidine, sotalol, tacrolimus, thioridazine, among others. kamagra orodispersibile online
cheapest place to ziprasidone, ziprasidone dsc tablets, ziprasidone where to order shopping, ziprasidone how to buy shop, buy ziprasidone dubai, price of generic ziprasidone without insurance, brand ziprasidone levels, cost for ziprasidone walmart, ziprasidone buy now pharmacy otc, generic ziprasidone online generic, buy cheap ziprasidone next day delivery, shop ziprasidone pct, buy ziprasidone yahoo, best price ziprasidone generic, ziprasidone originale, is online ziprasidone safe, order cheapest ziprasidone mastercard usa, cheap ziprasidone online pills, ziprasidone duo, cheapest ziprasidone online pills, cost for ziprasidone, ziprasidone cost publix, buy ziprasidone lloyds pharmacy, ziprasidone price compare, ziprasidone cheap order online visa, ziprasidone buy now online visa, ziprasidone cream pharmacy, brand ziprasidone basket, ziprasidone purchase mastercard canada, order cheap ziprasidone shop australia, generic ziprasidone usa to usa, cheapest ziprasidone purchase now pharmacy, generic ziprasidone pharmacy, purchase ziprasidone visa usa, prescription ziprasidone vs otc, network ziprasidone, where to buy real ziprasidone, ziprasidone orodispersibile online, average ziprasidone dosepak
There is a slight risk 1 in 1500 patients that ziprasidone by itself could significantly increase the QT interval. There is an even smaller risk 1 in 4000 patients that it could cause a potentially serious change in the rhythm of the heart. People with schizophrenia who get counseling are also more likely to stick with their medications. Elderly patients with a diagnosis of psychosis related to dementia. Ziprasidone hydrochloride capsules are not approved for the treatment of these patients. Positive, encouraging support from family and friends really helps, too. Ziprasidone also inhibits synaptic reuptake of serotonin and norepinephrine. estrace
As with other drugs that antagonize dopamine D 2 receptors, Ziprasidone elevates prolactin levels in humans. Ziprasidone hydrochloride capsules, 80 mg are size '2' capsules with dark blue opaque cap and white opaque body, imprinted axially with "LU" on cap and "V54" on body in black ink, containing off-white to pinkish granular powder. This information is generalized and not intended as specific medical advice. In animal studies Ziprasidone demonstrated developmental toxicity, including possible teratogenic effects at doses similar to human therapeutic doses.
There are many products available. Many can be purchased without a prescription. Some products require a prescription. Consult your doctor or on the choice of the product that is best for you. Although the mechanism of action of ziprasidone is not known, like other anti-psychotics, it inhibits communication between nerves of the brain. It does this by blocking receptors on the nerves for several neurotransmitters, the chemicals that nerves use to communicate with each other. Additionally, population pharmacokinetic evaluation of patients in controlled trials has revealed no evidence of clinically significant age or gender-related differences in the pharmacokinetics of Ziprasidone. Dosage modifications for age or gender are, therefore, not recommended. average flucort dosepak
Since Ziprasidone has the potential to impair judgment, thinking, or motor skills, patients should be cautioned about performing activities requiring mental alertness, such as operating a motor vehicle including automobiles or operating hazardous machinery until they are reasonably certain that Ziprasidone therapy does not affect them adversely. Ziprasidone is unlikely to interfere with the metabolism of drugs metabolized by cytochrome P450 enzymes. Do not drive a car or operate machinery until you know how this medication affects you. QTc interval have been associated with the occurrence of torsade de pointes and with sudden unexplained death.